UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Phase II Trial of Safety, Tolerability and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, Compared With 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants

The Pediatric infectious disease journal, 2020-08, Vol.39 (8), p.763-770

2020

Volltextzugriff (PDF)

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults

Human vaccines & immunotherapeutics, 2019-03, Vol.15 (3), p.530-539

2019

Volltextzugriff (PDF)

Development and Validation of Two Optimized Multiplexed Serologic Assays for the 9-Valent Human Papillomavirus Vaccine Types

mSphere, 2023-04, Vol.8 (2), p.e0096221-e0096221

2023

Volltextzugriff (PDF)

Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU)

Human vaccines & immunotherapeutics, 2022-12, Vol.18 (1), p.1-14

2022

Volltextzugriff (PDF)

The 15-valent pneumococcal conjugate vaccine V114 induces cross-reactive antibodies against pneumococcal serotype 6C

Human vaccines & immunotherapeutics, 2023-08, Vol.19 (2), p.2235238-2235238

2023

Volltextzugriff (PDF)

Three-Year Follow-up of 2-Dose Versus 3-Dose HPV Vaccine

Pediatrics (Evanston), 2021-01, Vol.147 (1), p.1

2021

Volltextzugriff (PDF)

Development and Validation of a Sensitive and Robust Multiplex Antigen Capture Assay to Quantify Streptococcus pneumoniae Serotype-Specific Capsular Polysaccharides in Urine

mSphere, 2022-08, Vol.7 (4), p.e0011422-e0011422

2022

Volltextzugriff (PDF)

V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies

PLoS pathogens, 2007-08, Vol.3 (8), p.e117-e117

2007

Volltextzugriff (PDF)

Effects of Partial Deletions within the Human Immunodeficiency Virus Type 1 V3 Loop on Coreceptor Tropism and Sensitivity to Entry Inhibitors

Journal of Virology, 2008-01, Vol.82 (2), p.664-673

2008

Volltextzugriff (PDF)

Characterization of a Human Immunodeficiency Virus Type 1 V3 Deletion Mutation That Confers Resistance to CCR5 Inhibitors and the Ability To Use Aplaviroc-Bound Receptor

Journal of Virology, 2009-04, Vol.83 (8), p.3798-3809

2009

Volltextzugriff (PDF)

Live attenuated Listeria monocytogenes expressing HIV Gag: Immunogenicity in rhesus monkeys

Vaccine, 2007-10, Vol.25 (42), p.7470-7479

2007

Volltextzugriff (PDF)

Replication-Competent Variants of Human Immunodeficiency Virus Type 2 Lacking the V3 Loop Exhibit Resistance to Chemokine Receptor Antagonists

Journal of Virology, 2007-09, Vol.81 (18), p.9956-9966

2007

Volltextzugriff (PDF)

Raising the Bar: Using Simulation to Advance Staff Competency Regarding the Patient Experience

Journal for nurses in professional development, 2020-09, Vol.36 (5), p.294

2020

Volltextzugriff (PDF)

Raising the Bar: Using Simulation to Advance Staff Competency Regarding the Patient Experience

Journal for nurses in professional development, 2020-09, Vol.36 (5), p.294-298

2020

Volltextzugriff (PDF)

P06 The 15-valent pneumococcal conjugate vaccine (PCV) V114 induces cross-reactive antibodies against pneumococcal serotype 6C

JAC-antimicrobial resistance, 2023-01, Vol.5 (Supplement_1)

2023

Volltextzugriff (PDF)

1972. Safety and Immunogenicity of 15-Valent Pneumococcal Conjugate Vaccine (PCV-15) Compared with PCV-13 in Healthy Older Adults Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23)

Open forum infectious diseases, 2018-11, Vol.5 (suppl_1), p.S572-S572

2018

Volltextzugriff (PDF)

Live attenuatedListeria monocytogenesexpressing HIV Gag: Immunogenicity in rhesus monkeys

Vaccine, 2007-10, Vol.25 (42), p.7470

2007

Volltextzugriff (PDF)

The role of the HIV-1 V3 loop in determining coreceptor tropism and modulating sensitivity to coreceptor inhibitors

Nolan, Katrina M

2008

Volltextzugriff (PDF)

The 15-valent pneumococcal conjugate vaccine V114 induces cross-reactive antibodies against pneumococcal serotype 6C

Human Vaccines & Immunotherapeutics, 2023, Vol.19 (2)

2023

Volltextzugriff (PDF)

Post-stroke lateropulsion and rehabilitation outcomes: a retrospective analysis

Disability and rehabilitation, 2022-09, Vol.44 (18), p.5162-5170

2022

Volltextzugriff (PDF)

Indicators of mental disorders in UK Biobank—A comparison of approaches

International journal of methods in psychiatric research, 2019-09, Vol.28 (3), p.e1796-n/a

2019

Volltextzugriff (PDF)

Kinetics of the Cellular and Transcriptomic Response to Eimeria maxima in Relatively Resistant and Susceptible Chicken Lines

Frontiers in immunology, 2021-03, Vol.12, p.653085-653085

2021

Volltextzugriff (PDF)

Cyclization of 4‑Phenoxy-2-coumarins and 2‑Pyrones via a Double C–H Activation

Organic letters, 2016-06, Vol.18 (11), p.2540-2543

2016

Volltextzugriff (PDF)

Current trends in rapid tests for mycotoxins

Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment, 2019-05, Vol.36 (5), p.800-814

2019

Volltextzugriff (PDF)

Accuracy of the Australian National Sub-Acute and Non-Acute Patient Classification in predicting rehabilitation length of stay for stroke survivors who are ≥65 years of age and have lateropulsion

Topics in stroke rehabilitation, 2023-03, Vol.30 (2), p.203-211

2023

Volltextzugriff (PDF)

1 – 25 von 70

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieBioanalysis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(63)

Publikationsform

Sprache

Englisch
(70)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Phase II Trial of Safety, Tolerability and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, Compared With 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults

Development and Validation of Two Optimized Multiplexed Serologic Assays for the 9-Valent Human Papillomavirus Vaccine Types

Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU)

The 15-valent pneumococcal conjugate vaccine V114 induces cross-reactive antibodies against pneumococcal serotype 6C

Three-Year Follow-up of 2-Dose Versus 3-Dose HPV Vaccine

Development and Validation of a Sensitive and Robust Multiplex Antigen Capture Assay to Quantify Streptococcus pneumoniae Serotype-Specific Capsular Polysaccharides in Urine

V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies

Effects of Partial Deletions within the Human Immunodeficiency Virus Type 1 V3 Loop on Coreceptor Tropism and Sensitivity to Entry Inhibitors

Characterization of a Human Immunodeficiency Virus Type 1 V3 Deletion Mutation That Confers Resistance to CCR5 Inhibitors and the Ability To Use Aplaviroc-Bound Receptor

Live attenuated Listeria monocytogenes expressing HIV Gag: Immunogenicity in rhesus monkeys

Replication-Competent Variants of Human Immunodeficiency Virus Type 2 Lacking the V3 Loop Exhibit Resistance to Chemokine Receptor Antagonists

Raising the Bar: Using Simulation to Advance Staff Competency Regarding the Patient Experience

Raising the Bar: Using Simulation to Advance Staff Competency Regarding the Patient Experience

P06 The 15-valent pneumococcal conjugate vaccine (PCV) V114 induces cross-reactive antibodies against pneumococcal serotype 6C

1972. Safety and Immunogenicity of 15-Valent Pneumococcal Conjugate Vaccine (PCV-15) Compared with PCV-13 in Healthy Older Adults Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23)

Live attenuatedListeria monocytogenesexpressing HIV Gag: Immunogenicity in rhesus monkeys

The role of the HIV-1 V3 loop in determining coreceptor tropism and modulating sensitivity to coreceptor inhibitors

The 15-valent pneumococcal conjugate vaccine V114 induces cross-reactive antibodies against pneumococcal serotype 6C

Post-stroke lateropulsion and rehabilitation outcomes: a retrospective analysis

Indicators of mental disorders in UK Biobank—A comparison of approaches

Kinetics of the Cellular and Transcriptomic Response to Eimeria maxima in Relatively Resistant and Susceptible Chicken Lines

Cyclization of 4‑Phenoxy-2-coumarins and 2‑Pyrones via a Double C–H Activation

Current trends in rapid tests for mycotoxins

Accuracy of the Australian National Sub-Acute and Non-Acute Patient Classification in predicting rehabilitation length of stay for stroke survivors who are ≥65 years of age and have lateropulsion

Aktive Filter

Suchergebnisse filtern